Identification of a novel, recurrent MBTD1‐CXorf67 fusion in low‐grade endometrial stromal sarcoma. Issue 5 (4th September 2013)
- Record Type:
- Journal Article
- Title:
- Identification of a novel, recurrent MBTD1‐CXorf67 fusion in low‐grade endometrial stromal sarcoma. Issue 5 (4th September 2013)
- Main Title:
- Identification of a novel, recurrent MBTD1‐CXorf67 fusion in low‐grade endometrial stromal sarcoma
- Authors:
- Dewaele, Barbara
Przybyl, Joanna
Quattrone, Anna
Finalet Ferreiro, Julio
Vanspauwen, Vanessa
Geerdens, Ellen
Gianfelici, Valentina
Kalender, Zeynep
Wozniak, Agnieszka
Moerman, Philippe
Sciot, Raf
Croce, Sabrina
Amant, Frederic
Vandenberghe, Peter
Cools, Jan
Debiec‐Rychter, Maria - Abstract:
- <abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Endometrial stromal sarcomas (ESSs) are a genetically heterogeneous group of rare uterine neoplasms that are commonly driven by recurrent gene rearrangements. In conventional low‐grade ESS, <italic>JAZF1‐SUZ12</italic>, <italic>PHF1‐JAZF1</italic>, <italic>EPC1‐PHF1</italic> and <italic>MEAF6‐PHF1</italic>, and recently described <italic>ZC3H7</italic>‐<italic>BCOR</italic> chimeric fusions have been reported in &gt; 50% of cases. Conversely, oncogenic t(10;17)(q22;p13) translocation yields YWHAE‐FAM22A/B chimeric proteins that are associated with histologically high‐grade and clinically more aggressive ESS. Integrating whole‐transcriptome paired‐end RNA sequencing with fluorescence <italic>in situ</italic> hybridization (FISH) and banding cytogenetics, we identified <italic>MBTD1</italic> (malignant brain tumor domain‐containing 1) and <italic>CXorf67</italic> (chromosome X open reading frame 67) as the genes involved in the novel reciprocal t(X;17)(p11.2;q21.33) translocation in two independent low‐grade ESS of classical histology. The presence of the <italic>MBTD1‐CXorf67</italic> fusion transcript was validated in both cases using reverse‐transcription polymerase chain reaction followed by Sanger sequencing. A specific FISH assay was developed to detect the novel t(X;17) translocation in formalin‐fixed paraffin‐embedded material, and resulted in identification of an additional<abstract abstract-type="main"> <title> <x xml:space="preserve">Abstract</x> </title> <p>Endometrial stromal sarcomas (ESSs) are a genetically heterogeneous group of rare uterine neoplasms that are commonly driven by recurrent gene rearrangements. In conventional low‐grade ESS, <italic>JAZF1‐SUZ12</italic>, <italic>PHF1‐JAZF1</italic>, <italic>EPC1‐PHF1</italic> and <italic>MEAF6‐PHF1</italic>, and recently described <italic>ZC3H7</italic>‐<italic>BCOR</italic> chimeric fusions have been reported in &gt; 50% of cases. Conversely, oncogenic t(10;17)(q22;p13) translocation yields YWHAE‐FAM22A/B chimeric proteins that are associated with histologically high‐grade and clinically more aggressive ESS. Integrating whole‐transcriptome paired‐end RNA sequencing with fluorescence <italic>in situ</italic> hybridization (FISH) and banding cytogenetics, we identified <italic>MBTD1</italic> (malignant brain tumor domain‐containing 1) and <italic>CXorf67</italic> (chromosome X open reading frame 67) as the genes involved in the novel reciprocal t(X;17)(p11.2;q21.33) translocation in two independent low‐grade ESS of classical histology. The presence of the <italic>MBTD1‐CXorf67</italic> fusion transcript was validated in both cases using reverse‐transcription polymerase chain reaction followed by Sanger sequencing. A specific FISH assay was developed to detect the novel t(X;17) translocation in formalin‐fixed paraffin‐embedded material, and resulted in identification of an additional low‐grade ESS case positive for the <italic>MBTD1‐CXorf67</italic> fusion among 25 uterine stromal tumors [14 ESS and 11 undifferentiated endometrial sarcomas (UESs)] that were negative for <italic>JAZF1</italic> and <italic>YWHAE</italic> rearrangements. Gene expression profiles of seven ESS (including three with <italic>YWHAE</italic> and two with <italic>JAZF1</italic> rearrangements) and four UES without specific chromosomal aberrations indicated clustering of tumors with <italic>MBTD1‐CXorf67</italic> fusion together with low‐grade <italic>JAZF1</italic>‐associated ESS. The chimeric <italic>MBTD1‐CXorf67</italic> fusion identifies yet another cytogenetically distinct subgroup of low‐grade ESS and offers the opportunity to shed light on the functions of two poorly characterized genes.</p> </abstract> … (more)
- Is Part Of:
- International journal of cancer. Volume 134:Issue 5(2014:Mar. 01)
- Journal:
- International journal of cancer
- Issue:
- Volume 134:Issue 5(2014:Mar. 01)
- Issue Display:
- Volume 134, Issue 5 (2014)
- Year:
- 2014
- Volume:
- 134
- Issue:
- 5
- Issue Sort Value:
- 2014-0134-0005-0000
- Page Start:
- 1112
- Page End:
- 1122
- Publication Date:
- 2013-09-04
- Subjects:
- Cancer -- Periodicals
Cancer -- Prevention -- Periodicals
616.994 - Journal URLs:
- http://onlinelibrary.wiley.com/journal/10.1002/(ISSN)1097-0215 ↗
http://onlinelibrary.wiley.com/ ↗ - DOI:
- 10.1002/ijc.28440 ↗
- Languages:
- English
- ISSNs:
- 0020-7136
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 4542.156000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 3493.xml